BBT-004

N/A

Report date: 2025/03/05 17:39:19

Base Information

Drug NameBBT-004

Drug Alias NameBBT-004BBT004

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsInflammatory Bowel DiseasesRheumatic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBambusa Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesBambusa Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsInflammatory Bowel DiseasesRheumatic Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A